$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What should I take after becoming resistant to erlotinib?
2026-02-01 22:25:32
Check Details
Can erlotinib be used in combination with chemotherapy?
2026-02-01 22:25:32
Check Details
How often should you review your blood routine while taking erlotinib?
2026-02-01 22:25:32
Check Details
Under what circumstances should erlotinib be adjusted or discontinued?
2026-02-01 22:25:32
Check Details
Are there always side effects of erlotinib?
2026-02-01 22:25:32
Check Details
How to deal with the resistance to erlotinib in patients with advanced lung cancer
2026-02-01 22:25:32
Check Details
How much is the latest price of Venetoclax in 2024?
2026-02-01 22:25:32
Check Details
How much does a box of 28 tablets of Venetoclax cost?
2026-02-01 22:25:32
Check Details
Will venetoclax be included in medical insurance in 2024?
2026-02-01 22:25:32
Check Details
Is venetoclax a self-paid drug?
2026-02-01 22:25:32
Check Details
How much is the medical insurance reimbursement price for Venetoclax?
2026-02-01 22:25:32
Check Details
Is venetoclax covered by medical insurance? How much?
2026-02-01 22:25:32
Check Details
1
2
...
1029
1030
1031
1032
1033
1034
1035
...
10223
10224
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Eltrombopag Administration Timing and Alternative Therapy Guide
2
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings
3
Avatrombopag: A Complete Guide to Dosage, Mechanism, and Clinical Use
4
Tazemetostat Dosage Guide: Laos Generic vs. Original Tazverik Comparison
5
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
6
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
7
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons
8
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
9
Venetoclax Clinical Guide: Mechanism, Indications, and Originator vs. Generic Comparison
10
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
11
Elagolix Side Effects and Safety Guide
12
Hetrombopag vs. Avatrombopag: Key Differences Between Two Oral TPO-RAs and Safety Considerations